NCT02671825View on ClinicalTrials.gov

A PK Study to Evaluate PUR0200 and a Reference Product in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Healthy
Interventions
DRUG

PUR0200

PUR0200 dry powder inhalation

DRUG

Reference Product

Dry Powder Inhalation Reference Product

Trial Locations (1)

1407

Tokuda Hospital, Sofia

All Listed Sponsors
lead

Pulmatrix Inc.

INDUSTRY

NCT02671825 - A PK Study to Evaluate PUR0200 and a Reference Product in Healthy Subjects | Biotech Hunter | Biotech Hunter